Beckman Coulter will be demonstrating its latest comprehensive solutions in microbiology, urinalysis, and hematology at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). During the conference, Beckman Coulter is also hosting a symposium where attendees will learn how the laboratory can help physicians detect antimicrobial resistance (AMR) and sepsis sooner.
Today's laboratories are facing more challenges than ever. Increasing concern over sepsis accelerates the need for accurate, rapid diagnosis. Coupled with the growing threat of emerging AMR, routine antibiotic susceptibility testing and minimum inhibitory concentration accuracy is needed to not only help detect AMR, but also to meet the clinical needs of all patients.
The symposium entitled, New Challenges in Clinical Microbiology: Faster Diagnosis of Sepsis and Critical Routine Susceptibility Testing, will be held at 4:00 pm on Monday, April 15, 2019 in hall C in the RAI Amsterdam.